Advancing Individualized Medicine
The Cluster for Individualized Immune Intervention (Ci3) e.V. is a non-profit organization with the aim of promoting the advancement of personalized medicine and individualized immunotherapies for the treatment of serious diseases such as cancer. By facilitating collaboration between academia, small and medium-sized enterprises, large corporations, regulators and the public, we are contributing to the development and establishment of innovative solutions in the healthcare sector.
DIGI-B-CUBE Virtual Matchmaking: Health meets IT – 22nd October 202011/09/2020
DIGI-B-CUBE Project – Results of First Open Call Published31/08/2020
Ci3 Cluster under new management08/05/2020
BioNTech and Pfizer announce approval from Paul-Ehrlich-Institute to commence first clinical trial in Germany for COVID-19 vaccine candidates22/04/2020